Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) insider Brenna Mcgibney sold 5,000 shares of the business’s stock in a transaction on Friday, March 7th. The shares were sold at an average price of $32.99, for a total value of $164,950.00. Following the transaction, the insider now owns 3,738 shares of the company’s stock, valued at approximately $123,316.62. The trade was a 57.22 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Trupanion Trading Up 2.3 %
TRUP opened at $33.20 on Wednesday. The stock’s fifty day moving average is $43.50 and its two-hundred day moving average is $47.33. The company has a market capitalization of $1.41 billion, a P/E ratio of -144.35, a PEG ratio of 6.02 and a beta of 1.70. Trupanion, Inc. has a 52 week low of $19.69 and a 52 week high of $57.90. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39.
Trupanion (NASDAQ:TRUP – Get Free Report) last released its quarterly earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by ($0.02). Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The firm had revenue of $337.31 million during the quarter, compared to analysts’ expectations of $335.41 million. Analysts forecast that Trupanion, Inc. will post 0.13 earnings per share for the current year.
Institutional Trading of Trupanion
Analyst Upgrades and Downgrades
A number of equities analysts recently issued reports on TRUP shares. Stifel Nicolaus dropped their price objective on Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a report on Thursday, February 20th. Piper Sandler dropped their price objective on Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a report on Thursday, February 20th. Two analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $46.60.
Get Our Latest Stock Report on Trupanion
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Stories
- Five stocks we like better than Trupanion
- What is a buyback in stocks? A comprehensive guide for investors
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- 5 Top Rated Dividend Stocks to Consider
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- How to Profit From Growth Investing
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.